A novel waterjet technology for transurethral cystoscopic injection of viable cells in the urethral sphincter complex. Issue 2 (24th December 2019)

• Record Type: Journal Article
• Authors: Jäger, Luise; Linzenbold, Walter; Fech, Andreas; Enderle, Markus; Abruzzese, Tanja; Stenzl, Arnulf; Aicher, Wilhelm K.
• Is Part Of: Neurourology and urodynamics. Volume 39:Issue 2(2020:Feb.)
• Page Start: 594
• Page End: 602
• Publication Date: 2019-12-24
• Subjects: cell injection -- cell therapy -- medical technology -- stress urinary incontinence -- waterjet; Urinary organs -- Periodicals; Urodynamics -- Periodicals; Urology -- Periodicals; 616.6
• DOI: 10.1002/nau.24261
• Languages: English
• ISSNs: 0733-2467

Abstract

Abstract: Aims: In a recent preclinical study, we noticed that injection of cells in the urethral sphincter by needle through a cystoscope under visual control frequently yielded in misplacement or loss of cells. We, therefore, investigated if a needle‐free waterjet device delivers viable cells under defined settings, including injection volume and pressure, fluid velocity and transportation media, precisely through the urothelium and connective tissue close to the sphincter muscle without full penetration of the sphincter apparatus. Methods: Mesenchymal stromal cells (MSCs) were prepared for needle‐free waterjet injections. Upon injections into liquids cell viability and yield were investigated by trypan blue dye exclusion. Upon injection into cadaveric urethral tissue samples, cells were isolated from the urethrae and expanded to prove that this novel method delivered viable cells into the tissue. MSC injections by William's needle served as controls. Results: Waterjet injections of MSCs into isotonic cell culture medium resulted in equal or better yields of viable cells when compared with needle injections. Upon injection in urethral tissue samples, the waterjet technology facilitated fast and precise injections of viable cells through urothelial, mucosal and submucosal layers to reach the sphincter muscle. By controlling the injection pressure, loss of cells due to insufficient thrust or unintended full penetration was avoided. Conclusions: Needle‐free waterjet injections deliver cells in the urethra faster and more precisely when compared with needle injections without compromising their viability. This is the first proof‐of‐concept study providing evidence that a waterjet transports viable cells precisely into the targeted tissue.